Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Deas

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Human Molecular Genetics|December 9, 2010
PINK1 cleavage at position A103 by the mitochondrial protease PARLEmma Deas, Helene Plun-Favreau, Sonia Gandhi, et al.
Plos One|May 3, 2013
Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injuryHilary K Siddall, Derek M Yellon, Sang-Bing Ong, et al.
Brain : a Journal of Neurology|March 17, 2009
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseJuliane Neumann, Jose Bras, Emma Deas, et al.
Nature Cell Biology|January 21, 2014
Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's diseaseRoberta Tufi, Sonia Gandhi, Inês P de Castro, et al.
Annals of Neurology|September 14, 2006
A heterozygous effect for PINK1 mutations in Parkinson's disease?Patrick M Abou-Sleiman, Miratul M K Muqit, Neil Q McDonald, et al.
Human Mutation|July 11, 2008
A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardationVera M Kalscheuer, Luciana Musante, Cheng Fang, et al.
Antioxidants & Redox Signaling|November 14, 2015
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's DiseaseEmma Deas, Nunilo Cremades, Plamena R Angelova, et al.
Cell|May 29, 2012
Direct observation of the interconversion of normal and toxic forms of α-synucleinNunilo Cremades, Samuel I A Cohen, Emma Deas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 11, 2012
The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's diseaseRaquel Duran, Niccolo E Mencacci, Aikaterini V Angeli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2015
Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formationSerene W Chen, Srdja Drakulic, Emma Deas, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Human Molecular Genetics|December 9, 2010
PINK1 cleavage at position A103 by the mitochondrial protease PARLEmma Deas, Helene Plun-Favreau, Sonia Gandhi, et al.
Plos One|May 3, 2013
Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injuryHilary K Siddall, Derek M Yellon, Sang-Bing Ong, et al.
Brain : a Journal of Neurology|March 17, 2009
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseJuliane Neumann, Jose Bras, Emma Deas, et al.
Nature Cell Biology|January 21, 2014
Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's diseaseRoberta Tufi, Sonia Gandhi, Inês P de Castro, et al.
Annals of Neurology|September 14, 2006
A heterozygous effect for PINK1 mutations in Parkinson's disease?Patrick M Abou-Sleiman, Miratul M K Muqit, Neil Q McDonald, et al.
Human Mutation|July 11, 2008
A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardationVera M Kalscheuer, Luciana Musante, Cheng Fang, et al.
Antioxidants & Redox Signaling|November 14, 2015
Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's DiseaseEmma Deas, Nunilo Cremades, Plamena R Angelova, et al.
Cell|May 29, 2012
Direct observation of the interconversion of normal and toxic forms of α-synucleinNunilo Cremades, Samuel I A Cohen, Emma Deas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 11, 2012
The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's diseaseRaquel Duran, Niccolo E Mencacci, Aikaterini V Angeli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2015
Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formationSerene W Chen, Srdja Drakulic, Emma Deas, et al.
Pageof 3